Varenicline‐induced erosive stomatitis: First case report-Reference-Cited by-同舟云学术

Varenicline‐induced erosive stomatitis: First case report

Published:2022-01-03 Issue: Volume: Page:
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:Contact Dermatitis

Author:

Pose Katherine¹^ORCID,Morales‐Cabeza Cristina¹,De Las Vecillas Leticia¹^ORCID,González Muñoz Miguel²,Feito‐Rodriguez Marta³,Fiandor Ana¹⁴

Affiliation:

1. Department of Allergy La Paz University Hospital Madrid Spain

2. Department of Immunology La Paz University Hospital Madrid Spain

3. Department of Dermatology La Paz University Hospital Madrid Spain

4. Department of Allergy La Paz University Hospital. Institute for Health Research (IdiPAZ) Madrid Spain

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cod.14026

Reference7 articles.

1. National Center for Biotechnology Information.PubChem Compound Summary for CID 170361 Varenicline.https://pubchem.ncbi.nlm.nih.gov/compound/Varenicline. Accessed August 30 2021.

2. Pubchem. Open Chemistry Database.Compound Summary for CID 170361. Varenicline.https://pubchem.ncbi.nlm.nih.gov/compound/170361. Accessed September 14 2021.

3. Varenicline‐induced acute generalized exanthematous pustulosis confirmed by patch testing;Özkaya E;Contact Dermatitis,2017

4. Varenicline‐induced symmetrical drug‐related intertriginous and flexural exanthema;Chung W;Indian J Dermatol Venereol Leprol,2019

5. The lymphocyte transformation test in the diagnosis of drug hypersensitivity

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2022-04

2. Comment on: “Varenicline‐induced erosive stomatitis: First case report”;Contact Dermatitis;2022-02-07